rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gil Todd Silva

Director

Company insider

Files Form 4 as: Director, ClearSign Technologies.

In numbers

Trades disclosed
24
Buys
3
Sells
0
Bought
$55K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
1 Aug 2024
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CLIR ClearSign TechnologiesDirector · Life-science tools · last 30 Sep 20263 buys · 0 sells

Activity over time

1 Mar – 1 Oct
02Mar 26May 26Jul 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—4,225 at $0.00filing
30 Sep 2026filed 2 Oct 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—3,766 at $0.00filing
30 Jun 2026filed 2 Jul 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—4,087 at $0.00filing
30 Jun 2026filed 2 Jul 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—4,595 at $0.00filing
30 Jun 2026filed 2 Jul 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—4,087 at $0.00filing
30 Jun 2026filed 2 Jul 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—4,595 at $0.00filing
23 Apr 2026filed 27 Apr 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$5,3191,000 at $5.32filing
23 Apr 2026filed 27 Apr 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$5,2501,000 at $5.25filing
23 Apr 2026filed 27 Apr 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$5,3201,000 at $5.32filing
23 Apr 2026filed 27 Apr 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$5,2501,000 at $5.25filing
31 Mar 2026filed 2 Apr 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—3,440 at $0.00filing
31 Mar 2026filed 2 Apr 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—3,024 at $0.00filing
31 Mar 2026filed 2 Apr 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—3,440 at $0.00filing
31 Mar 2026filed 2 Apr 2026CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—3,024 at $0.00filing
17 Mar 2026filed 19 Mar 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$8,4002,000 at $4.20filing
17 Mar 2026filed 19 Mar 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$8,4002,000 at $4.20filing
16 Mar 2026filed 19 Mar 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$8,7102,000 at $4.36filing
16 Mar 2026filed 19 Mar 2026CLIR ClearSign TechnologiesLife-science toolsSEC FORM 4 Bought$8,7202,000 at $4.36filing
1 Oct 2025filed 3 Oct 2025CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—26,830 at $0.00filing
1 Jul 2025filed 3 Jul 2025CLIR ClearSign Technologiesoption or derivative · Life-science toolsSEC FORM 4 Code A—32,638 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Anthony DigiandomenicoDirector · Director at ClearSign Technologies, filing Form 4 there in the last year
Lou BaseneseDirector · Director at ClearSign Technologies, filing Form 4 there in the last year
Larry Michael SaddlerDirector · Director at ClearSign Technologies, filing Form 4 there in the last year
John M. Pasquesi10% owner · 10% owner at ClearSign Technologies, filing Form 4 there in the last year
Colin James DellerChief Executive Officer · Chief Executive Officer at ClearSign Technologies, filing Form 4 there in the last year